Vimarsana
Biggest News Aggregation in the World

Page 5 - Combination Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Combination Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Combination Therapy Today - Breaking & Trending Today

Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mid-Winter Conference Focuses on Theranostics, AI, Diagnostic Imaging Innovations and Clinical Trials - Vimarsana News

Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mid-Winter Conference Focuses on Theranostics, AI, Diagnostic Imaging Innovations and Clinical Trials

This year’s Mid-Winter Conference of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) drew global experts exchanging the latest innovations in diagnostic and molecular imaging, cancer therapies, clinical trials and theranostics, as well as the potential role of artificial intelligence (AI) in nuclear medicine during the Feb. 1-3, 2024 meeting in Orlando, FL.

Considerations for Combination Therapy and MRD Testing in Newly Diagnosed Multiple Myeloma Patients - Vimarsana News

Considerations for Combination Therapy and MRD Testing in Newly Diagnosed Multiple Myeloma Patients

A medical expert navigates the treatment landscape for patients newly diagnosed with multiple myeloma.

Source: ajmc.com
FDA Greenlights First AI-Powered Device to Detect All 3 Common Skin Cancers - Vimarsana News

FDA Greenlights First AI-Powered Device to Detect All 3 Common Skin Cancers

The US Food and Drug Administration (FDA) has cleared the first AI-powered handheld medical device to assist physicians in detecting common skin cancers.

Combination Therapy for AD - Vimarsana News

Combination Therapy for AD

Physician assistant Andera Nguyen shares her experience on combination therapy and class switching.

Insights from ELEVATE-RR and Considerations for Combination Therapy in R/R CLL - Vimarsana News

Insights from ELEVATE-RR and Considerations for Combination Therapy in R/R CLL

Oncology experts discuss findings from ELEVATE-RR and outline key considerations for combination with acalabrutinib plus obinutuzumab.